https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/14/issue/9
Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences.
APSB is a monthly journal, in English, which publishes significant original research articles, rapid communications and high-quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
Articles of interest in this issue include:
Recent advances to address challenges in extracellular vesicle-based applications for lung cancer by Gaigai Huang, Wenshu Zheng, Yu Zhou, Meihua Wan and Tony Hu (https://doi.org/10.1016/j.apsb.2024.06.010). This review discusses lung cancer management challenges and explores the potential of extracellular vesicles (EVs) for personalized treatment and diagnosis, focusing on enhancing clinical translation through advanced engineering technologies.
Heme oxygenase 1-mediated ferroptosis in Kupffer cells initiates liver injury during heat stroke by Ru Li, Riqing Wei, Chenxin Liu et al. (https://doi.org/10.1016/j.apsb.2024.05.007). This study elucidates the intricate molecular mechanisms underpinning heat stroke-induced liver injury, highlighting the diverse responses of Kupffer cell (KC) subsets and the pivotal role of HMOX-1 in orchestrating ferroptosis in KCs, particularly in KC2, and NLRP3 inflammasome activation.
Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH by Ziqi Huang, Kun Zhang, Yurui Jiang et al. (https://doi.org/10.1016/j.apsb.2024.06.001). A novel "molecular glue", LXH-3-71, was discovered to degrade PHGDH by facilitating formation of the dynamic chimera between PHGDH and DDB1-CRL E3 ligase in CRC cells.
In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases by Yuan Li, Fan Tong, Yufan Wang et al. (https://doi.org/10.1016/j.apsb.2024.06.003). A smart tumor in situ nano-vaccine Tra/CpG@Man-P/Gel was constructed, and the size of nanoadjuvants was optimixed, to induce potent antitumor immunity and inhibit the primary and metastatic tumors.
Other articles include:
Review Articles
Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
Aaron T. Kao, Christian V. Cabanlong, Kendra Padilla, Xiang Xue
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, Lifeng Yu, ... Minjie Wei
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
Xiaokun Zhang, Ye Wu, Jiayi Lin, Shengxin Lu, ... Xin Luan
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, Nuo Cheng, ... Lei Wang
Yaxian Zheng, Shiqin Luo, Min Xu, Qin He, ... Yuan Huang
Original Articles
Yumeng Wang, Chengxi Li, Jianping Li, Shu Zhang, ... Jianming Guo
Zezhong Mou, Yiling Chen, Jinzhong Hu, Yun Hu, ... Haowen Jiang
Wenkang Fu, Yanyan Lin, Mingzhen Bai, Jia Yao, ... Wenbo Meng
Bin Li, Qi Xiao, Hongmei Zhao, Jianuo Zhang, ... Haitao Liu
Weilian Bao, Jiaren Lyu, Guize Feng, Linfeng Guo, ... Xiaoyan Shen
Junqi Hu, Yinlong Li, Chenchen Dong, Huiyi Wei, ... Weijian Ye
Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics
Chris Chun-Yiu Chan, Qian Guo, Jasper Fuk-Woo Chan, Kaiming Tang, ... Shuofeng Yuan
Ke Zhang, Jinru Jia, Ting Li, Wenjing Liu, ... Yuelin Song
CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy
Xiaoyu Wu, Zijun Bai, Hui Wang, Hanqing Wang, ... Weiwei Tao
Mengru Cai, Tingting Fu, Rongyue Zhu, Panxiang Hu, ... Jian Ni
Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, Haoxiang Wang, ... Jianliang Shen
Mengyi Yan, Xiayun Chen, Xiaotong Li, Qianqian Liu, ... Shiying Li
Establishing cell suitability for high-level production of licorice triterpenoids in yeast
Wentao Sun, Shengtong Wan, Chuyan Liu, Ruwen Wang, ... Chun Li
Xinyun Jian, Cheng Wang, Shijuan Wu, Guo Sun, ... Yuhui Sun
Short Communication
SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites
Kaixiang Zhu, Lili Song, Linyue Wang, Lei Hua, ... Sheng Cui
Letters to the Editor
Juan Zhang, Min Zhang, Qi-Meng Zhu, Xin-Rong Xu, ... Cheng-Peng Sun
Mingkun Huang, Yufang Hu, Ling Zhang, Hua Yang, ... Wei Sun
Highlights
Advancing cancer nanomedicine with machine learning
Xifeng Qin, Tun Lu, Zhiqing Pang
PEGylated bacteria restore intestinal mucosal barrier
Menghang Zu, Xue Xia, Bo Xiao
Mianling Yang, Meehyein Kim, Peng Zhan
# # # # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board
APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).
Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).
CiteScore: 22.4
Impact Factor: 14.7 (Top 5 journal in the category of Pharmacology and pharmacy)
JIF without self-citation: 13.9
ISSN 2211-3835
# # # # #